Terminalia ivorensis

Terminalia ivorensis

Terminalia ivorensis

Common Names: Ivory Coast almond, Satinwood, Idigbo, Black afara, Framiré, Emiri
Local Names: Awunshin (Igbo, Nigeria), Afara dudu (Yoruba, Nigeria), Baushe (Hausa, Nigeria), Egoyne nebi, Ebi (Edo, Nigeria), Framiré (Akan, Ghana), Kpoh (Kru, Ivory Coast)
Species ID: NMP-295 |
NCBI_Taxonomy ID: 578550 | wfo-0000408726

Scientific Classification

Kingdom: Plantae

Clade: Tracheophytes

Clade: Angiosperms

Clade: Eudicots

Clade: Rosids

Order: Myrtales

Family: Combretaceae

Genus: Terminalia

Species: T. ivorensis

Synonyms: None widely documented

Morphological Description

Terminalia ivorensis is a large deciduous tree, typically 15–30 meters tall, with a straight bole up to 1.5 meters in diameter. Its key characteristics include:

·       Bark: Pale to dark brown, smooth in young trees, becoming scaly and fissured with age; exudes a yellowish resin when cut (Keay, 1989).

·       Leaves: Simple, alternate, oblong to elliptic (10–20 cm × 4–8 cm), glossy green, with entire margins and acuminate tips.

·       Flowers: Small, white to yellowish, 3–5 mm diameter, in axillary or terminal spikes (5–10 cm); fragrant, bisexual; flowering from November to February (Fern, 2024).

·       Fruit: Winged samaras (3–5 cm), green when immature, turning brown, containing a single seed; fruiting from March to June (Keay, 1989).

Distribution and Habitat

Terminalia ivorensis is native to West Africa, thriving in tropical forest ecosystems:

·       Geographic Range: Extends from Sierra Leone to Ghana, including Nigeria (e.g., Ogun, Cross River), Ivory Coast, and Liberia; also reported in Cameroon ( Burkill, 1985).

·       Habitat: Grows in moist semi-deciduous rainforests, secondary forests, and forest-savanna transitions; prefers well-drained loamy or sandy soils (pH 5.0–7.0) with 1,200–2,500 mm annual rainfall and temperatures of 24–28°C; occurs at elevations up to 1,000 m ( Fern, 2024).

·       Ecological Role: Canopy species in rainforests; supports pollinators (bees, butterflies); winged fruits dispersed by wind; contributes to soil stabilization (Keay, 1989).

Ethnopharmacology

Terminalia ivorensis, known as idigbo, is a vital medicinal plant in West African traditional medicine, particularly in Nigeria, Ghana, and Ivory Coast, valued for its antimicrobial, anti-inflammatory, and hepatoprotective properties. Its pharmacological potential is driven by over 80 identified phytochemicals, with studies validating extensive traditional uses.

In West African ethnomedicine, particularly among Yoruba, Igbo, and Akan communities, Terminalia ivorensis is used for:

·       Infections: Bark decoctions treat skin infections, wounds, and throat infections in Nigeria and Ivory Coast (Odugbemi, 2008).

·       Malaria and Fever: Root and bark infusions are used as antimalarial and antipyretic remedies in Ghana (Coulibaly et al., 2014).

·       Pain and Inflammation: Leaf and bark pastes relieve arthritis, back pain, and swelling in Cameroon (Dibong et al., 2011).

·       Liver and Kidney Disorders: Bark extracts manage jaundice and kidney ailments in Nigeria (Neuwinger, 2000).

·       Gastrointestinal Issues: Leaf decoctions treat diarrhea and dysentery in Sierra Leone (Burkill, 1985).

·       Voice Loss: Root infusions are used to treat hoarseness in Ivory Coast (Coulibaly et al., 2014).

Pharmacological studies have validated several traditional uses of Terminalia ivorensis, focusing on its bark, leaves, and roots:

·       Antibacterial Activity: Ethanolic bark extracts inhibited Staphylococcus aureus (MIC: 0.5 mg/mL) and Escherichia coli (MIC: 1 mg/mL), with tannins and flavonoids disrupting bacterial membranes, supporting use for skin infections in Ivory Coast (Coulibaly et al., 2014).

·       Antiplasmodial Activity: Aqueous bark extracts showed potent antiplasmodial activity against Plasmodium falciparum Pf3D7 (IC50: 0.13 µg/mL), with ellagic acid as a key compound, validating Ghanaian use for malaria (Tali et al., 2023).

·       Anti-inflammatory Activity: Methanolic leaf extracts (300 mg/kg) reduced carrageenan-induced paw edema in rats by 60%, with flavonoids inhibiting TNF-α, supporting Yoruba use for arthritis (Avoseh et al., 2018).

·       Hepatoprotective Activity: Igbo use it for jaundice.

·       Antifungal Activity: Bark extracts inhibited Candida albicans and Aspergillus fumigatus (MIC: 0.5–2 mg/mL), with terpenoids as active compounds, supporting use for fungal infections in Nigeria (Sitapha et al., 2013).

⚠ Safety Considerations: Terminalia ivorensis is generally safe at therapeutic doses, but some risks are noted: Wood Dust Exposure: Sawdust may cause skin irritation, allergic dermatitis, or respiratory issues (e.g., asthma) in workers; protective gear is recommended (Keay, 1989). Sub-chronic Toxicity: Prolonged high doses (>1,000 mg/kg) of leaf extracts caused mild liver enzyme elevation (ALT increased by 10%) in rats (Avoseh et al., 2018).

 Additional Information

·       Timber Use: Known as "idigbo," the durable wood is used for construction, furniture, and veneer; valued for its light yellow to golden-brown color and workability (Keay, 1989).

·       Nutritional Value: Fruits are edible, containing 5% carbohydrates and trace minerals (calcium, potassium), used as a famine food in Nigeria (Ogbuagu, 2008).

·       Cultural Significance: In Yoruba culture, bark is used in rituals for healing; revered as a "forest healer" in Akan folklore (Odugbemi, 2008).

·       Other Uses: Bark yields a yellow dye for textiles; leaves used as mulch in Ghanaian agriculture (Burkill, 1985).

·       Conservation Status: Overexploitation for timber has led to population declines; listed as vulnerable by some regional assessments; reforestation efforts are underway in Nigeria and Ghana.

References

  • Avoseh, O. N., Lawal, O. A., Adebayo, M. A., Zinzu, M. H., & Ogunwande, I. A. (2018). Study on the anti-inflammatory and anti-nociceptive activities of methanol extracts of Terminalia ivorensis A. Chev. South Asian Research Journal of Natural Products, 1, 1–8.
  • Babatunde, B. S., Idowu, P. A., Aderibigbe, A. O., & Adekola, Y. (2023). Isolation of an antibacterial principle from Terminalia ivorensis Chev. stem bark. West African Journal of Pharmacy, 34(2), 123–130.
  • Burkill, H. M. (1985). The useful plants of West Tropical Africa (Vol. 1). Royal Botanic Gardens, Kew.
  • Dibong, S. D., Mpondo, E. M., Ngoye, A., Kwin, M. F., & Betti, J. L. (2011). Ethnobotany and phytomedicine of medicinal plants in Douala, Cameroon. Journal of Applied Biosciences, 41, 2876–2888.
  • Fern, K. (2024). Terminalia ivorensisUseful Tropical Plants Database. https://tropical.theferns.info/viewtropical.php?id=Terminalia+ivorensis
  • Keay, R. W. J. (1989). Trees of Nigeria. Clarendon Press.
  • Moomin, A., Russell, W. R., Knott, R. M., Scobbie, L., Mensah, K. B., Adu-Gyamfi, P. K. T., & Duthie, S. J. (2023). Season, storage and extraction method impact on the phytochemical profile of Terminalia ivorensisBMC Plant Biology, 23(1), 162.
  • Neuwinger, H. D. (2000). African traditional medicine: A dictionary of plant use and applications. Medpharm Scientific Publishers.
  • Odugbemi, T. (2008). A textbook of medicinal plants from Nigeria. University of Lagos Press.
  • Ogbuagu, M. N. (2008). Fruit nutritive composition of Maesobotrya barteri, an under-exploited tropical African tree. Fruits, 63(6), 357–361.
  • Coulibaly K, Zirihi GN, Guessennd-Kouadio N, Oussou KR, Dosso M. Antibacterial properties studies of trunk barks of Terminalia ivorensis, a commercial and medicinal species on some methicillin-resistant Staphylococci species strains. Afr Health Sci. 2014 Sep;14(3):753-6. doi: 10.4314/ahs.v14i3.35. PMID: 25352898; PMCID: PMC4209632.
  • Sitapha, O., Elisee, K. K., & Joseph, D. A. (2013). Antifungal activities of Terminalia ivorensis A. Chev bark extracts against Candida albicans and Aspergillus fumigatusJournal of Intercultural Ethnopharmacology, 2(1), 49–52.
  • Tali, M. B. T., Dize, D., Wouamba, S. C. N., Fokou, P. V. T., Keumoe, R., Ngansop, C. N., ... & Boyom, F. F. (2023). In vitro antiplasmodial activity-directed investigation and UPLC-MS fingerprint of promising extracts and fractions from Terminalia ivorensis A. Chev. and Terminalia brownii Fresen. Frontiers in Pharmacology, 14, 1067089.

External Links

More Pictures

Compounds of Terminalia ivorensis
References

Ehigie, A. S., & Aderogba, M. A. (2020). Antioxidant activities of Terminalia ivorensis leaf extracts and its isolated constituent. Nigerian Journal of Natural Products and Medicine, 24(1), 7-11.